Delivery Order SPE2DB20D3104-SPE2DB25FV6F8

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a medical product, with a ceiling value of $1,546.66 and a period of performance through March 28, 2025. The contract is a firm-fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TUBERSOL 5T UNIT/0.1 ML VIALML. The contract has a ceiling value of $1,709.38 and an ultimate completion date of April 27, 2023. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, valued at $1,070.95, with a completion date of February 11, 2025. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.00, is for the delivery of TUBERSOL 5T UNIT/0.1 ML VIALML, a medical product, with a completion date of March 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA) for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML. The contract has a ceiling value of $2,612.40 and an ultimate completion date of December 9, 2024. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation, to provide TUBERSOL 5T UNIT/0.1 ML VIAL 5ML pharmaceutical products. The contract has a potential value of $1,262.58 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA through December 2025, which serves as...
This contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order valued at $7,338.40 for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of February 16, 2024. Amerisourcebergen Drug Corp has an Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB20D2002|SPE2DB25FL39N, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,850.32 firm fixed-price delivery order is for the supply of 4,568,092,129 units of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML, with a performance period ending on May 1, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant...
The Defense Logistics Agency Troop Support Medical awarded a $268,750 delivery order to Amerisourcebergen Drug Corporation for Tubersol 5T vaccine units. The firm fixed price order is for delivery of 0.1 ml vials of the vaccine to a location in Conshohocken, Pennsylvania. Performance will take place between July 11-12, 2023. No additional details were provided about the original solicitation or whether this delivery order is associated with an existing contract vehicle. The prime contractor is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of TENIVAC SYRINGE 0.5ML. The contract has a firm fixed price of $4,171.55 and an ultimate completion date of August 1, 2024. The contract is not set aside for any socioeconomic program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB25FV6F8
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TUBERSOL 5T UNIT/0.1 ML VIAL 5ML. The award has a ceiling value of $2,141.90 and an ultimate completion date of April 4, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/3/25, 2:48 PM